Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hidetaka Sumiyoshi"'
Autor:
Souichi Kitaguchi, Shinichi Miyamori, Masaaki Noda, Yasuhiko Sakata, Yasuki Tomoda, Chie Hamai, Kouichi Hiraki, Utae Yonezawa, Nobue Uetake, Hidetaka Sumiyoshi, Yasuo Iwamoto
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:717-722
Nausea and vomiting due to chemotherapy not only reduce quality of life but also cause suspension or extension of therapy,or reductions in the dosages of agents used,and influence therapeutic effects.Their control is therefore extremely important.In
Autor:
Motoki Matsuura, Toshiya Fujiwara, Noritomo Seno, Yasuo Iwamoto, Hidetaka Sumiyoshi, Kazuhiko Kataoka
Publikováno v:
Haigan. 48:850-855
背景.肺硬化性血管腫は,術中迅速病理検査にて腺癌と診断されたという報告が散見される腫瘍である.症例.25歳の女性が,検診にて肺腫瘍を指摘された.胸部X線写真では,左下肺野
Autor:
Hidetaka Sumiyoshi, Toshiya Fujiwara, Izumi Nakamura, Kazuhiko Kataoka, Noritomo Seno, Motoki Matsuura
Publikováno v:
Haigan. 48:861-865
背景.薄壁空洞病変を呈する原発性肺癌はまれである.症例.51歳女性が,右下肺野の薄壁空洞を呈する胸部異常影にて入院した.CTにて,右S10に65×30 mmの薄壁空洞病変が認められた.空
Autor:
Hidetaka Sumiyoshi, Masao Doi, Keiko Fukuhara, Masao Kuwabara, Hiroyuki Maeda, Masahiro Yamasaki, Shintaro Miyamoto
Publikováno v:
Therapy. 3:773-777
We compared two chemotherapy regimens for advanced non small-cell lung cancer. The CG regimen consisted of carboplatin (AUC 4 to 5) on day 1 plus gemcitabine (1,000 mg/m(2)) on day 1 and 8, every three weeks, while the CP regimen was carboplatin (AUC
Autor:
Hidetaka Sumiyoshi, Teruomi Miyazawa, Masao Doi, Koji Kanoh, Yuka Miyazu, Mika Zaima, Yasuo Iwamoto, Atsuko Ishida
Publikováno v:
Respirology. 11:90-97
Objective: To evaluate the efficacy of combined intrapleural therapy with cisplatin, an antineoplastic agent, and OK432, a sclerosing agent, in controlling malignant pleural effusions, when compared with monotherapy with either agent. Methods: A tota
Autor:
Yasushiro Fujiwara, Toshiaki Takahashi, Merrill J Egorin, Nobuoki Kohno, Tetsuya Oguri, Terumasa Ohune, Hidetaka Sumiyoshi, Mitsuru Miyazaki
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 1:92-97
To clarify the clinical pharmacological profile of etoposide in the elderly, we carried out prospective therapeutic drug monitoring in 14 patients with advanced lung cancer aged 75 or more years. The patients received 50 mg etoposide as oral capsules
Autor:
Yuka Miyazu, Koji Kanoh, Atsuko Ishida, Yasuo Iwamoto, Teruomi Miyazawa, Masao Doi, Hidetaka Sumiyoshi, Noriaki Kurimoto
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 169:1096-1102
Airway stenting at the wave-speed flow-limiting segment (the choke point) is assessed. We determined prospectively the precise location of the choke point using the flow-volume curve, endobronchial ultrasonography, ultrathin bronchoscopy, and three-d
Autor:
Naoki Yamaoka, Michio Yamakido, Yasuhiro Fujiwara, Hidetaka Sumiyoshi, Keiko Tamura, Terumasa Ohune
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 670:309-316
A simplified method for the simultaneous determination of irinotecan (CPT-11, I) and its active metabolite (SN-38, II) in human plasma by high-performance liquid chromatography (HPLC) with fluorescence detection has been developed. Following the addi
Publikováno v:
Japanese Journal of Cancer Research : Gann
Twenty-eight patients with inoperable or relapsed lung cancer were given a combination of oral etoposide, administered once a day at doses ranging from 40 to 60 mg/m2/day (d) for 21 consecutive days, and carboplatin, administered intravenously over 1
Autor:
Torn Miyoshi, Hidetaka Sumiyoshi, Takeshi Shimomura, Teruomi Miyazawa, Masao Morihara, Makoto Furonaka, Hiroo Matsuura
Publikováno v:
Journal of Bronchology. 6:186-188